MedWatch

Danish medical equipment company to introduce product on the US market

Medical Prognosis Institute expects to market diagnostic equipment for cancer patients at the end of the year. The newly appointed CEO of the company is a former Topotarget executive.

The relatively small Danish medical equipment company focused on diagnostics, Medical Prognosis Institute (MPI), could – if all goes well – be headed for the American market with two new products by the end of the year. The company’s core product, which has been under development for seven years, is a piece of diagnostic equipment aimed at cancer patients, a so-called Drug Response Predictor.

“With our diagnostic equipment we can predict which cancer patients will respond to, say, chemotherapy – that is, it can predict whether or not the patients’ tumor will disappear,” says company founder and Chief Research Officer Steen Knudsen. He is a former professor at the Danish Technical University, DTU, and has written several books about DNA Microarrays, also known as DNA-chips.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Antibiotikaalliance får yderligere milliarder til at bekæmpe resistens

Den internationale antibiotikaalliance Carb-X har fået tilsagn om yderligere 370 mio. dollar til at accelerere udviklingen af ny antibiotika og håndtere den stigende resistens over for lægemidler. Milliardindsprøjtningen vækker begejstring hos danske aktører, for som det er nu, fungerer markedet for antibiotika ikke, lyder det.

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier